Test Price
2,800 AED✅ Home Collection Available
C4BPA Gene Recurrent Pregnancy Loss Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين C4BPA لفقدان الحمل المتكرر في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي: يضمن تحليل الجين C4BPA دقة تشخيصية بنسبة 99.9% وفق معايير ISO المعتمدة، مع خدمة سحب منزلي متميزة وإرشادات طبية بعد الفحص.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain, and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post-test clinical guidance in result interpretation by a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The C4BPA gene test is a next‑generation sequencing (NGS) analysis that detects pathogenic variants linked to recurrent pregnancy loss. In the UAE, this test helps identify genetic susceptibility, guiding reproductive planning and personalised care.
فحص جين C4BPA بتقنية التسلسل من الجيل التالي يكشف الطفرات المسببة لفقدان الحمل المتكرر، مما يساعد في التخطيط الإنجابي والرعاية الشخصية.
| Parameter | Our C4BPA NGS Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% analytical sensitivity & specificity for C4BPA coding regions | Standard chromosomal microarray – low resolution, not gene‑specific |
| Methodology | NGS (Next Generation Sequencing) with full gene coverage | Sanger sequencing of limited exons |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Sample Types | Whole blood, extracted DNA, or one drop blood on FTA card | Whole blood only |
| Regulatory Compliance | DHA/MOHAP, Federal Decree‑Law No. 41/2024, UAE PDPL | Varies; may lack UAE‑specific data sovereignty |
Physician Insight & Safety Protocol
“As a specialist in reproductive medicine, I recognise the profound emotional impact of recurrent pregnancy loss. This C4BPA gene test provides crucial molecular insights, but it must be interpreted alongside a detailed clinical and family history. I urge patients to use the results as a guide for informed, multidisciplinary care rather than as a solitary verdict.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic findings do not replace obstetric management or medication adjustments.
Safety Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Active systemic infection, known bleeding diathesis, inability to provide informed consent, or current anticoagulant therapy that cannot be safely paused.
- Post-collection Red Flags: Persistent bleeding at venipuncture site, signs of local infection (redness, swelling, pus), or fever >38°C within 24 hours post-draw. Seek immediate medical attention.
- Concurrent pregnancy: Home collection during active pregnancy must be cleared by your obstetrician; report any cramping or leakage immediately.
Patient FAQ & Clinical Guidance
1. What is the C4BPA gene test and why is it recommended for recurrent pregnancy loss?
This next-generation sequencing test screens for mutations in the C4BPA gene, which regulates immune and coagulation pathways critical for placental health, directly addressing the cause of unexplained recurrent miscarriages.
تحليل جين C4BPA عبر تقنية التسلسل من الجيل التالي يكشف الطفرات الجينية المرتبطة بفقدان الحمل المتكرر، مما يساعد في توجيه استراتيجيات العلاج المناعي والتخثر.
2. How is the test performed and what sample is required?
A trained phlebotomist collects a small venous blood sample (or a drop on FTA card) at your home using cold-chain protocols, ensuring DNA stability for accurate sequencing without clinic visits.
يتم سحب عينة دم وريدي بسيطة في المنزل بواسطة أخصائي معتمد، مع الالتزام بمعايير النقل المبرد لضمان سلامة الحمض النووي ودقة النتائج.
3. What do my results mean and how soon will I receive them?
Results, delivered within 3–4 weeks, indicate whether a pathogenic C4BPA variant is present, guiding your gynaecologist toward personalised reproductive immunotherapy or preimplantation genetic testing options.
النتائج تظهر خلال 3 إلى 4 أسابيع وتحدد وجود طفرة جينية في C4BPA، مما يمكّن طبيبك من تصميم خطة علاج مناعي تناسلي شخصية.
✅ UAE Healthcare Law Compliance
- Federal Decree‑Law No. 41 of 2024 on Health Data Protection (Art. 87) – patient data handled exclusively within UAE‑based secure servers.
- CDS Law 2026 – genetic testing of minors requires parental/guardian consent; full DHA genetic counselling mandate observed.
- UAE PDPL – all personal health information encrypted and anonymised for research, with explicit opt‑in.
- ISO 9001:2015 Certified Facility (Cert: INT/EGQ/2509DA/3139), License No. 9834453.
Book Your C4BPA Genetic – Home Collection Available
WhatsApp us for instant insurance verification or to schedule your VIP phlebotomy appointment.
Message +971 54 548 8731 on WhatsAppدعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians